PatientsVille.com Logo

PatientsVille

Mevalotin Side Effects

Common Mevalotin Side Effects


The most commonly reported Mevalotin side effects (click to view or check a box to report):

Rhabdomyolysis (28)
Liver Disorder (11)
Blood Creatine Phosphokinase Increased (10)
Cerebral Infarction (10)
Aspartate Aminotransferase Increased (10)
Platelet Count Decreased (7)
Alanine Aminotransferase Increased (7)
Asthma (6)
Asthenia (6)
Computerised Tomogram Abnormal (6)
Hepatic Function Abnormal (6)
Hypertension (6)
Musculoskeletal Pain (5)
Gait Disturbance (5)
Oedema Peripheral (5)
Pneumonia (5)
Renal Failure Acute (5)
Idiopathic Thrombocytopenic Purpura (4)
Vasculitis (4)
Jaundice (4)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Mevalotin Side Effects Reported to FDA

The following Mevalotin reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Mevalotin on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Colon Cancer
This is a report of a 65-year-old male patient (weight: NA) from JP, suffering from the following symptoms/conditions: NA, who was treated with Mevalotin (dosage: NA, start time: Nov 28, 2012), combined with:
  • Crestor
  • Actos
  • Glycoran
  • Amaryl
  • Amaryl
  • Olmetec
  • Olmetec
  • Livalo (pitavastatin Calcium)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Colon Cancer
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Mevalotin treatment in male patients, resulting in colon cancer side effect.

Ascites, Pleural Effusion
This report suggests a potential Mevalotin Ascites, Pleural Effusion side effect(s) that can have serious consequences. A 61-year-old female patient (weight: NA) from JP was diagnosed with the following symptoms/conditions: NA and used Mevalotin (dosage: 20 Mg, Unk) starting Feb 29, 2012. Soon after starting Mevalotin the patient began experiencing various side effects, including:
  • Ascites
  • Pleural Effusion
Drugs used concurrently:
  • Xyzal (1 Df, Unk)
  • Xyzal (5 Mg, Unk)
  • Pegasys (90 ?g, Unk)
  • Pegasys (45 ?g, Unk)
  • Adalat (20 Mg, Qd)
  • Methycobal (1500 ?g, Unk)
  • Methycobal (150 ?g, Unk)
  • Vx-950 (1500 Mg, Qd)
Although Mevalotin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as ascites, may still occur.

B-cell Lymphoma
This B-cell Lymphoma problem was reported by a physician from JAPAN. A female patient (weight: NA) was diagnosed with the following symptoms/conditions: hyperlipidaemia,rheumatoid arthritis. On Jan 09, 2007 this consumer started treatment with Mevalotin (dosage: NA). The following drugs were being taken at the same time:
  • Rheumatrex
  • Remicade (Total Number Of Infusions = 1)
  • Mucosta
  • Remicade (Total Number Of Infusions = 1)
  • Evista
  • Etodolac
When commencing Mevalotin, the patient experienced the following unwanted symptoms/side effects:
  • B-cell Lymphoma
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as b-cell lymphoma, may become evident only after a product is in use by the general population.

Cardiac Failure Acute
This is a report of a female patient (weight: NA) from SWITZERLAND. The patient developed the following symptoms/conditions: NA and was treated with Mevalotin (dosage: NA) starting Oct 20, 2009. Concurrently used drugs:
  • Aspirin
  • Takepron (Unk)
  • Diovan
  • Prednisolone (Unk)
  • Prednisolone (Unk)
  • Unifyl (Unk)
  • Acinon (Unk)
  • Omalizumab (300 Mg, Q2w)
Soon after that, the consumer experienced the following side effects:
  • Cardiac Failure Acute
The patient was hospitalized. This opens a possibility that Mevalotin treatment could cause the above reactions, including cardiac failure acute, and some female subjects may be more susceptible.


Fall, Cerebral Haemorrhage
A female patient (weight: NA) from JAPAN with the following symptoms/conditions: dyslipidaemia,hypertension started Mevalotin treatment (dosage: 10 Mg, Unk) on Sep 12, 2009. Soon after starting Mevalotin treatment, the subject experienced various side effects, including:
  • Fall
  • Cerebral Haemorrhage
Concurrently used drugs:
  • Co-diovan (1 Df, Unk)
The patient was hospitalized. This finding indicates that some female patients could be more vulnerable to Mevalotin.

Bradycardia, Hypotension, Ventricular Fibrillation
A 67-year-old female patient from JAPAN (weight: NA) experienced symptoms, such as: dyslipidaemia,hypertension,blood glucose abnormal,hypersensitivity and was treated with Mevalotin(dosage: 10mg Daily). The treatment was initiated on Dec 20, 2010. After that a consumer reported the following side effect(s):
  • Bradycardia
  • Hypotension
  • Ventricular Fibrillation
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Mevalotin efficacy:
  • Norvasc (10mg Daily)
  • Lantus (10 Iu, 1x/day)
  • Allelock (5mg Daily)
The patient was hospitalized.

Bradycardia, Ventricular Fibrillation, Hypotension
In this report, Mevalotin was administered for the following condition: dyslipidaemia,hypertension,blood glucose abnormal,hypersensitivity.A 67-year-old female consumer from JAPAN (weight: NA) started Mevalotin treatment (dosage: 10mg Daily) on Dec 20, 2010.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Bradycardia
  • Ventricular Fibrillation
  • Hypotension
A possible interaction with other drugs could have contributed to this reaction:
  • Norvasc (10mg Daily)
  • Lantus (10 Iu, 1x/day)
  • Allelock (5mg Daily)
The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Mevalotin treatment could be related to the listed above side effect(s).

Hepatic Function Abnormal, Dysphonia, Hypophosphataemia, Lipase Increased, Blood Amylase Increased
This is a report of the following Mevalotin side effect(s):
  • Hepatic Function Abnormal
  • Dysphonia
  • Hypophosphataemia
  • Lipase Increased
  • Blood Amylase Increased
A 78-year-old male patient from JAPAN (weight: NA) presented with the following condition: NA and received a treatment with Mevalotin (dosage: NA) starting: Apr 03, 2008.The following concurrently used drugs could have generated interactions:
  • Nexavar
This report suggests that a Mevalotin treatment could be associated with the listed above side effect(s).

Femur Fracture
This Mevalotin report was submitted by a 68-year-old female consumer from JAPAN (weight: NA). The patient was diagnosed with: hyperlipidaemia,hypothyroidism,osteoporosis and Mevalotin was administered (dosage: NA) starting: Jun 29, 2000. The consumer developed a set of symptoms:
  • Femur Fracture
Other drugs used simultaneously:
  • Thyradin-s
  • Alfarol
  • Fosamax
  • Aspara Ca
The patient was hospitalized.Those unexpected symptoms could be linked to a Mevalotin treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Muscle Spasms
This is a report of a possible correlation between Mevalotin use and the following symptoms/side effect(s):
  • Muscle Spasms
which could contribute to an assessment of Mevalotin risk profile.A 72-year-old female consumer from JAPAN (weight: NA) was suffering from NA and was treated with Mevalotin (dosage: NA) starting Jan 24, 2011.Other concurrent medications:
  • Aspirin
  • Candesartan Cilexetil And Hydrochlorothiazide


Convulsion
A 72-year-old female patient from JAPAN (weight: NA) presented with the following symptoms: NA and after a treatment with Mevalotin (dosage: NA) experienced the following side effect(s):
  • Convulsion
The treatment was started on Jan 24, 2011. Mevalotin was used in combination with the following drugs:
  • Aspirin
  • Ecard Combination Hd
This report could alert potential Mevalotin consumers.

Hypoglycaemia, Renal Failure Acute
In this report, a 74-year-old male patient from JAPAN (weight: NA) was affected by a possible Mevalotin side effect.The patient was diagnosed with NA. After a treatment with Mevalotin (dosage: NA, start date: NS), the patient experienced the following side effect(s):
  • Hypoglycaemia
  • Renal Failure Acute
The following simultaneously used drugs could have led to this reaction:
  • Amlodipine
  • Amaryl
  • Nu-lotan
The findings here stress that side effects should be taken into consideration when evaluating a Mevalotin treatment.

Neutrophil Count Decreased, Biliary Tract Infection, Thrombocytopenia, Neutropenia
This is a report of a female patient from JAPAN (weight: NA), who used Mevalotin (dosage: NA) for a treatment of NA. After starting a treatment on Dec 11, 2010, the patient experienced the following side effect(s):
  • Neutrophil Count Decreased
  • Biliary Tract Infection
  • Thrombocytopenia
  • Neutropenia
The following drugs could possibly have interacted with the Mevalotin treatment
  • Revlimid
  • Methycobal
  • Tenormin
  • Aspirin
  • Revlimid
  • Lenadex
  • Myslee
  • Lenadex
The patient was hospitalized.Taken together, these observations suggest that a Mevalotin treatment could be related to side effect(s), such as Neutrophil Count Decreased, Biliary Tract Infection, Thrombocytopenia, Neutropenia.

Rhabdomyolysis
This rhabdomyolysis side effect was reported by a physician from JAPAN. A 76-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA. The patient was prescribed Mevalotin (dosage: NA), which was started on Nov 23, 2010. Concurrently used drugs:
  • Lendormin D
  • Methylcobal
  • Baktar
  • Decadron
  • Zyloric
  • Maxipime
  • Cravit
  • Revlimid
When starting to take Mevalotin the consumer reported the following symptoms:
  • Rhabdomyolysis
The patient was hospitalized. These side effects may potentially be related to Mevalotin.

Cognitive Disorder
This is a Mevalotin side effect report of a 78-year-old female patient (weight:NA) from JAPAN, suffering from the following symptoms/conditions: NA, who was treated with Mevalotin (dosage:NA, start time: NS), combined with:
  • Nauzelin
  • Halcion (0.25 Mg, 1x/day)
  • Selbex
  • Alfarol
  • Tagamet
, and developed a serious reaction and a cognitive disorder side effect. The patient presented with:
  • Cognitive Disorder
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Mevalotin treatment in female patients suffering from NA, resulting in cognitive disorder.

Hepatitis Fulminant, Renal Failure Acute
This report suggests a potential Mevalotin hepatitis fulminant side effect(s) that can have serious consequences. A 65-year-old male patient from JAPAN (weight:NA) was diagnosed with the following health condition(s): hyperlipidaemia and used Mevalotin (dosage: NA) starting May 02, 2008. Soon after starting Mevalotin the patient began experiencing various side effects, including:
  • Hepatitis Fulminant
  • Renal Failure Acute
Drugs used concurrently:
  • Actos
  • Micardis
  • Norvasc
  • Metformin Hcl
  • Amaryl
  • Basen (Basen Od)
  • Epadel
Although Mevalotin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as hepatitis fulminant, may still occur.

C-reactive Protein Increased, Headache, Liver Disorder
This c-reactive protein increased problem was reported by a health professional from JAPAN. A 64-year-old male patient (weight: NA) was diagnosed with the following medical condition(s): hyperlipidaemia,rheumatoid arthritis.On Aug 10, 2007 a consumer started treatment with Mevalotin (dosage: NA). The following drugs/medications were being taken at the same time:
  • Rheumatrex
  • Selbex (Restarted-07may08; 50mg 3 In 1 Day.)
  • Foliamin
  • Gaster (Interrupted On 2005,restarted On 07-may-2008.)
When commencing Mevalotin, the patient experienced the following unwanted symptoms /side effects:
  • C-reactive Protein Increased
  • Headache
  • Liver Disorder
The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as c-reactive protein increased, may become evident only after a product is in use by the general population.

Leukopenia
This is a Mevalotin side effect report of a 83-year-old female patient (weight: NA) from JAPAN. The patient developed the following symptoms/conditions: hyperlipidaemia,hypertension,back pain and was treated with Mevalotin (dosage: NA) starting NS. Concurrently used drugs:
  • Acecol
  • Loxonin
  • Famotidine
  • Bonalon
  • Juvela N
  • Coniel
  • Mucosta
Soon after that, the consumer experienced the following of symptoms:
  • Leukopenia
The patient was hospitalized. This opens a possibility that Mevalotin could cause leukopenia and that some female patients may be more susceptible.

Platelet Count Decreased
A 75-year-old female patient (weight: NA) from JAPAN with the following symptoms: hypercholesterolaemia started Mevalotin treatment (dosage: NA) on Dec 15, 2007. Soon after starting Mevalotin treatment, the consumer experienced several side effects, including:
  • Platelet Count Decreased
. Concurrently used drugs:
  • Amaryl
  • Basen
  • Lansoprazole
  • Aspirin
  • Herbal Mixture
This finding indicates that some patients can be more vulnerable to developing Mevalotin side effects, such as platelet count decreased.

Headache, Liver Disorder
This headache side effect was reported by a health professional from JAPAN. A 64-year-old male patient (weight:NA) experienced the following symptoms/conditions: hyperlipidaemia.The patient was prescribed Mevalotin (dosage: NA), which was started on Aug 10, 2007. Concurrently used drugs:
  • Rheumatrex
  • Selbex (Restarted On 6-may-2008)
  • Foliamin
  • Famotidine (Interrupted On 2005,restarted On 09-may-2008.)
.When starting to take Mevalotin the consumer reported symptoms, such as:
  • Headache
  • Liver Disorder
These side effects may potentially be related to Mevalotin. The patient was hospitalized.

Platelet Count Decreased
This is a report of a 75-year-old female patient (weight: NA) from JAPAN, suffering from the following symptoms/conditions: hypercholesterolaemia, who was treated with Mevalotin (dosage: NA, start time: Jan 18, 2008), combined with:
  • Amaryl
  • Basen
  • Takepron
  • Aspirin
  • Herbal Mixture
and developed a serious reaction and side effect(s). The consumer presented with:
  • Platelet Count Decreased
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Mevalotin treatment in female patients, resulting in platelet count decreased side effect.

Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, C-reactive Protein Increased
This report suggests a potential Mevalotin Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, C-reactive Protein Increased side effect(s) that can have serious consequences. A 64-year-old male patient (weight: NA) from JAPAN was diagnosed with the following symptoms/conditions: lipids abnormal and used Mevalotin (dosage: NA) starting Jan 01, 2004. Soon after starting Mevalotin the patient began experiencing various side effects, including:
  • Alanine Aminotransferase Increased
  • Aspartate Aminotransferase Increased
  • C-reactive Protein Increased
Drugs used concurrently:
  • Rheumatrex
  • Selbex (Interrupted On 2005.restarted On 01may08.)
  • Foliamin
  • Famotidine (Interrupted On 2005,restarted On 09-may-2008.)
The patient was hospitalized. Although Mevalotin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as alanine aminotransferase increased, may still occur.

Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, C-reactive Protein Increased
This Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, C-reactive Protein Increased problem was reported by a health professional from JAPAN. A 64-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Jan 01, 2004 this consumer started treatment with Mevalotin (dosage: NA). The following drugs were being taken at the same time:
  • Selbex
  • Rheumatrex
  • Foliamin
  • Famotidine
When commencing Mevalotin, the patient experienced the following unwanted symptoms/side effects:
  • Alanine Aminotransferase Increased
  • Aspartate Aminotransferase Increased
  • C-reactive Protein Increased
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as alanine aminotransferase increased, may become evident only after a product is in use by the general population.

Cerebral Infarction, Rhabdomyolysis
This is a report of a 65-year-old female patient (weight: NA) from JAPAN. The patient developed the following symptoms/conditions: hyperlipidaemia,systemic lupus erythematosus,osteoporosis,cerebral infarction and was treated with Mevalotin (dosage: NA) starting NS. Concurrently used drugs:
  • Predonine
  • Bonalon
  • Aspirin
  • Mucosta
  • Adalat
  • Prograf
  • Alosenn
  • Serenal
Soon after that, the consumer experienced the following side effects:
  • Cerebral Infarction
  • Rhabdomyolysis
The patient was hospitalized. This opens a possibility that Mevalotin treatment could cause the above reactions, including cerebral infarction, and some female subjects may be more susceptible.

Asthenia, Asthma, Cerebral Arteriosclerosis, Cerebral Infarction, Computerised Tomogram Abnormal, Gait Disturbance, Hypertension, Vasculitis
A 63-year-old female patient (weight: NA) from JAPAN with the following symptoms/conditions: NA started Mevalotin treatment (dosage: 10 Mg, Unk) on Dec 29, 2007. Soon after starting Mevalotin treatment, the subject experienced various side effects, including:
  • Asthenia
  • Asthma
  • Cerebral Arteriosclerosis
  • Cerebral Infarction
  • Computerised Tomogram Abnormal
  • Gait Disturbance
  • Hypertension
  • Vasculitis
Concurrently used drugs:
  • Pariet (10 Mg, Unk)
  • Gasmotin (15 Mg, Unk)
  • Primperan Inj (15 Mg, Unk)
  • Diovan (80 Mg, Qd)
  • Serevent (100 Ug)
  • Salmeterol Xinafoate
  • Loxonin (180 Mg, Unk)
  • Kipres (10 Mg, Unk)
The patient was hospitalized. This finding indicates that some female patients could be more vulnerable to Mevalotin.

1 of 5 



Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Mevalotin Side Effects

    Did You Have a Mevalotin Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Mevalotin for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Mevalotin Safety Alerts, Active Ingredients, Usage Information

    More About Mevalotin

    Side Effects reported to FDA: 111

    Mevalotin safety alerts: No

    Reported deaths: 12

    Reported hospitalizations: 79

    Latest Mevalotin clinical trials

    Mevalotin Reviews

    No reviews, be a first to report a side effect via side effect reporting form